Genfit (GNFT) News Today $3.50 +0.07 (+1.89%) As of 01/17/2025 03:59 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 Time Period Genfit S.A. (NASDAQ:GNFT) Sees Significant Growth in Short InterestGenfit S.A. (NASDAQ:GNFT - Get Free Report) was the target of a large growth in short interest in December. As of December 31st, there was short interest totalling 63,400 shares, a growth of 6.0% from the December 15th total of 59,800 shares. Based on an average daily volume of 10,100 shares, the days-to-cover ratio is currently 6.3 days. Approximately 0.1% of the shares of the company are sold short.January 19 at 10:18 PM | marketbeat.comComparing Voyager Therapeutics (NASDAQ:VYGR) and Genfit (NASDAQ:GNFT)January 19 at 2:21 AM | americanbankingnews.comGENFIT: Half-Year Report of Liquidity Contract with Crédit Industriel et CommercialJanuary 13, 2025 | globenewswire.comGenfit S.A. (NASDAQ:GNFT) Short Interest Down 6.3% in DecemberGenfit S.A. (NASDAQ:GNFT - Get Free Report) was the recipient of a significant decline in short interest in the month of December. As of December 15th, there was short interest totalling 59,800 shares, a decline of 6.3% from the November 30th total of 63,800 shares. Approximately 0.1% of the shares of the company are short sold. Based on an average daily trading volume, of 12,300 shares, the days-to-cover ratio is currently 4.9 days.December 31, 2024 | marketbeat.comEuropean Equities Traded in the US as American Depositary Edge Higher in Thursday TradingDecember 26, 2024 | msn.comGenfit (NASDAQ:GNFT) Shares Down 3.8% - Here's What HappenedGenfit (NASDAQ:GNFT) Trading Down 3.8% - Time to Sell?December 12, 2024 | marketbeat.comEuropean Equities Traded in the US as American Depositary Decline in Tuesday TradingNovember 26, 2024 | msn.comGenfit Balances Ipsen Partnership With High-Risk Pipeline AmbitionsNovember 21, 2024 | seekingalpha.comGENFIT S.A.: GENFIT Announces Corporate Updates and Upcoming Participation at The Liver Meeting 2024November 17, 2024 | finanznachrichten.deGENFIT Announces Corporate Updates and Upcoming Participation at The Liver Meeting® 2024November 13, 2024 | globenewswire.comGenfit’s Revenue Surge Driven by Key MilestoneNovember 8, 2024 | markets.businessinsider.comGENFIT Reports Third Quarter 2024 Financial InformationNovember 7, 2024 | globenewswire.comEuropean Equities Traded in the US as American Depositary Receipts Close Bearish Week on High Note FridayNovember 1, 2024 | msn.comEuropean Equities Traded in the US as American Depositary Receipts Down Sharply in Wednesday TradingOctober 30, 2024 | msn.comGenfit S.A. (NASDAQ:GNFT) Sees Significant Increase in Short InterestGenfit S.A. (NASDAQ:GNFT - Get Free Report) was the recipient of a large growth in short interest during the month of September. As of September 30th, there was short interest totalling 67,800 shares, a growth of 16.5% from the September 15th total of 58,200 shares. Based on an average daily volume of 10,700 shares, the days-to-cover ratio is presently 6.3 days. Currently, 0.1% of the shares of the company are short sold.October 16, 2024 | marketbeat.comGenfit (GNFT) Earnings Dates & ReportsOctober 16, 2024 | investing.comGenfit's (GNFT) Buy Rating Reaffirmed at HC WainwrightHC Wainwright reissued a "buy" rating and set a $13.00 price target on shares of Genfit in a research note on Friday.October 11, 2024 | marketbeat.comEuropean Equities Traded in the US as American Depositary Receipts Higher in Friday TradingOctober 4, 2024 | msn.comEuropean Equities Traded in the US as American Depositary Receipts Decline in Tuesday TradingOctober 1, 2024 | msn.comGENFIT: Ipsen's Iqirvo® (Elafibranor) Receives EU Approval as a First-in-Class Treatment for Primary Biliary Cholangitis following U.S. FDA Accelerated ApprovalSeptember 23, 2024 | globenewswire.comLeerink Partnrs Analysts Lift Earnings Estimates for Genfit S.A. (NASDAQ:GNFT)Genfit S.A. (NASDAQ:GNFT - Free Report) - Equities researchers at Leerink Partnrs boosted their FY2024 earnings per share (EPS) estimates for shares of Genfit in a report released on Thursday, September 19th. Leerink Partnrs analyst T. Smith now anticipates that the company will post earnings ofSeptember 23, 2024 | marketbeat.comGenfit (NASDAQ:GNFT) Rating Reiterated by HC WainwrightHC Wainwright reissued a "buy" rating and issued a $13.00 price objective on shares of Genfit in a research report on Friday.September 20, 2024 | marketbeat.comEuropean Equities Traded in the US as American Depositary Receipts Rise in Friday Trading; Poised to End Week HigherSeptember 13, 2024 | msn.comGenfit (NASDAQ:GNFT) Trading Down 2%Genfit (NASDAQ:GNFT) Shares Down 2%September 11, 2024 | marketbeat.comGenfit (NASDAQ:GNFT) Stock Price Down 0.2%Genfit (NASDAQ:GNFT) Trading Down 0.2%August 20, 2024 | marketbeat.comGenfit S.A. (GNFTF)August 16, 2024 | finance.yahoo.comEuropean Equities Traded in the US as American Depositary Receipts Rise in Tuesday TradingAugust 6, 2024 | msn.comGENFIT S.A.: Positive Opinion from EMA Committee for Ipsen's Iqirvo (elafibranor) in Primary Biliary CholangitisJuly 27, 2024 | finanznachrichten.deGENFIT: Positive Opinion from EMA Committee for Ipsen's Iqirvo® (elafibranor) in Primary Biliary CholangitisJuly 26, 2024 | globenewswire.comGenfit (NASDAQ:GNFT) Shares Down 3.8% Genfit (NASDAQ:GNFT) Trading Down 3.8%July 24, 2024 | marketbeat.comGENFIT: Half-Year Report of Liquidity Contract with Crédit Industriel et CommercialJuly 9, 2024 | globenewswire.comGenfit S.A. (NASDAQ:GNFT) Sees Large Growth in Short InterestGenfit S.A. (NASDAQ:GNFT - Get Free Report) saw a significant growth in short interest in the month of May. As of May 31st, there was short interest totalling 89,800 shares, a growth of 5.8% from the May 15th total of 84,900 shares. Currently, 0.2% of the company's shares are short sold. Based on an average trading volume of 19,900 shares, the short-interest ratio is presently 4.5 days.June 18, 2024 | marketbeat.comGENFIT: New EASL-EASD-EASO Clinical Practice Guidelines for MASLD Include NIS2+® as Key Tool for Detecting At-Risk MASHJune 17, 2024 | globenewswire.comFY2027 EPS Estimates for Genfit S.A. Reduced by HC Wainwright (NASDAQ:GNFT)Genfit S.A. (NASDAQ:GNFT - Free Report) - Equities research analysts at HC Wainwright decreased their FY2027 earnings per share (EPS) estimates for Genfit in a note issued to investors on Tuesday, June 11th. HC Wainwright analyst E. Arce now forecasts that the company will post earnings per shareJune 13, 2024 | marketbeat.comGENFIT: Historic Milestone Achieved with U.S. FDA Accelerated Approval of Ipsen's Iqirvo® for Primary Biliary CholangitisJune 10, 2024 | globenewswire.comUS FDA approves Genfit and Ipsen's liver disease drugJune 10, 2024 | reuters.comGENFIT to Present Latest ACLF Research at EASL Congress™ 2024May 29, 2024 | globenewswire.comGENFIT: May 22, 2024 Combined Shareholders Meeting ResultsMay 22, 2024 | globenewswire.comShort Interest in Genfit S.A. (NASDAQ:GNFT) Decreases By 5.8%Genfit S.A. (NASDAQ:GNFT - Get Free Report) was the target of a large decrease in short interest during the month of April. As of April 30th, there was short interest totalling 88,000 shares, a decrease of 5.8% from the April 15th total of 93,400 shares. Based on an average daily volume of 6,000 shares, the short-interest ratio is presently 14.7 days. Approximately 0.2% of the company's shares are short sold.May 17, 2024 | marketbeat.comHC Wainwright Reaffirms Buy Rating for Genfit (NASDAQ:GNFT)HC Wainwright reiterated a "buy" rating and set a $11.00 price target on shares of Genfit in a report on Wednesday.May 15, 2024 | marketbeat.comGENFIT S.A.: GENFIT Reports First Quarter 2024 Financial InformationMay 15, 2024 | finanznachrichten.deGENFIT Reports First Quarter 2024 Financial InformationMay 14, 2024 | globenewswire.comGenfit (NASDAQ:GNFT) Stock Price Up 1.2%Genfit (NASDAQ:GNFT) Stock Price Up 1.2%April 27, 2024 | marketbeat.comGENFIT: Publication of the 2024 Extra-Financial Performance Report (fiscal year 2023)April 25, 2024 | globenewswire.comGENFIT Annual Combined General Meeting of May 22, 2024 — Availability of Preparatory DocumentsApril 15, 2024 | globenewswire.comGENFIT Announces Publication of the 2023 Universal Registration Document and the 2023 Annual Report on Form 20-FApril 5, 2024 | globenewswire.comGenfit's (GNFT) Buy Rating Reiterated at HC WainwrightHC Wainwright reiterated a "buy" rating and issued a $11.00 target price on shares of Genfit in a research note on Friday.April 5, 2024 | marketbeat.comGENFIT S.A.: GENFIT Reports Full-Year 2023 Financial Results and Provides Corporate UpdateApril 5, 2024 | finanznachrichten.deGENFIT Reports Full-Year 2023 Financial Results and Provides Corporate UpdateApril 4, 2024 | globenewswire.comEuropean Equities Traded in the US as American Depositary Receipts Trend Higher in Wednesday TradingApril 3, 2024 | msn.com Get Genfit News Delivered to You Automatically Sign up to receive the latest news and ratings for GNFT and its competitors with MarketBeat's FREE daily newsletter. Email Address GNFT Media Mentions By Week GNFT Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. GNFT News Sentiment▼0.240.44▲Average Medical News Sentiment GNFT News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. GNFT Articles This Week▼31▲GNFT Articles Average Week Get Genfit News Delivered to You Automatically Sign up to receive the latest news and ratings for GNFT and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Replimune Group News uniQure News Pliant Therapeutics News Pharming Group News ORIC Pharmaceuticals News 89bio News Evolus News Bicara Therapeutics News Immatics News Immunome News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:GNFT) was last updated on 1/20/2025 by MarketBeat.com Staff From Our PartnersLast time you’ll see this priced at $1.00When was the last time you bought something for a buck? I don’t even think you can buy anything at McDonalds f...StocksToTrade | SponsoredBill Gates’ is about to mint millionaires (again) with Stargate.This little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredJanuary 29th - the next big trading catalyst to watch Mark your calendar for January 29th. Because on that day, I believe we could see a $2 Trillion shock INTO t...Timothy Sykes | SponsoredTop Picks for Trump’s Pro-Crypto AmericaThe Crypto ETF Windfall: 27 Experts Tell All (Free) Don't miss your chance to see exactly what crypto's eli...Crypto 101 Media | SponsoredWarren Buffett Bets $40 Billion—You Can Get in for $20I call it "The Last Retirement Stock You'll Ever Need." Warren Buffett himself owns $40 billion of stock in...Behind the Markets | SponsoredKamala’s final humiliation The investments connected to Trump's second term in ways that almost nobody outside his inner circle is aware ...Porter & Company | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Genfit S.A. Please log in to your account or sign up in order to add this asset to your watchlist. Share Genfit With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free GNFT Stock Alerts